Prostanoids as regulators of innate and adaptive immunity.
Potent, oxygenated lipid molecules called prostanoids regulate a wide variety of physiological responses and pathological processes. Prostanoids are produced by various cell types and act on target cells through specific G protein-coupled receptors. Although prostanoids have historically been considered acute inflammation mediators, studies using specific receptor knockout mice indicate that prostanoids, in fact, regulate various aspects of both innate and adaptive immunity. Each prostanoid, depending on which receptor it acts on, exerts specific effects on immune cells such as macrophages, dendritic cells, and T and B lymphocytes, often in concert with microbial ligands and cytokines, to affect the strength, quality, and duration of immune responses. Prostanoids are also relevant to immunopathology, from inflammation to autoimmunity and cancer. Here, we review the role of prostanoids in regulating immunity, their involvement in immunopathology, and areas of insight that may lead to new therapeutic opportunities.
Department of Pharmacology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Takako
T
Hirata
Shuh
S
Narumiya
D056704:Adaptive Immunity; D000818:Animals; D006801:Humans; D007154:Immune System Diseases / Q000503:physiopathology; D007113:Immunity, Innate; D011453:Prostaglandins / Q000276:immunology* / Q000378:metabolism; D011982:Receptors, Prostaglandin / Q000378:metabolism
D011453:Prostaglandins; D011982:Receptors, Prostaglandin